SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Shodell, M
Right arrow Articles by Siegal, F P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shodell, M
Right arrow Articles by Siegal, F P
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration

M Shodell

Section of HIV Medicine, Department of Medicine, Saint Vincents Catholic Medical Center, New York, USA, Long Island University, CW Post Campus, Brookville, New York, USA

K Shah

Section of HIV Medicine, Department of Medicine, Saint Vincents Catholic Medical Center, New York, USA

F P Siegal

Section of HIV Medicine, Department of Medicine, Saint Vincents Catholic Medical Center, New York, USA, fsiegal{at}saintvincentsnyc.org

Plasmacytoid dendritic cells (pDC), the major interferon-producingcell type found in human blood, have been implicated in the pathogenesisof systemic lupus erythematosus (SLE). Previous studies in SLE have shown substantial deviations from normal in this minor but immunologically important leukocyte population.Many of the lupus patients studied were receiving corticosteroids.To determine the effects of steroid administration on pDC in healthy adults, four volunteerswere given prednisone, 15-30 mg daily, for 4 days. Both counts of pDC, and their ability to produceIFN-were significantly reduced (P 0.02 and 0.004, respectively) during steroid administration, and rapidly recovered after discontinuation of the hormones. The overall reduction in pDC-derived IFN appeared to be attributable to falls of both number of circulating cells and of IFN produced per pDC. The effects observed with pDC were comparable in magnitude but opposite in direction to that observed for granulocytes. In contrast, other blood leukocytes were little affected during steroid therapy.

Key Words: corticosteroids • interferon • plasmacytoid dendritic cells • systemic lupus erythematosus

Lupus, Vol. 12, No. 3, 222-230 (2003)
DOI: 10.1191/0961203303lu362xx


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
N. BRAUN, P. FRITZ, A. RIETH, W. SCHROTH, M. KIMMEL, D. BIEGGER, D. ZAKIM, and M. D. ALSCHER
Predictors for Treatment Success and Expression of Glucocorticoid Receptor in Giant Cell Arteritis and Polymyalgia Rheumatica
J Rheumatol, October 1, 2009; 36(10): 2269 - 2276.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. A. Greenberg
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications
Neurology, November 20, 2007; 69(21): 2008 - 2019.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Plskova, K. Greiner, E. Muckersie, L. Duncan, and J. V. Forrester
Interferon-{alpha}: A Key Factor in Autoimmune Disease?
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3946 - 3950.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. O. Kvale, J. Dalgaard, F. Lund-Johansen, H. Rollag, L. Farkas, K. Midtvedt, F. L. Jahnsen, J. E. Brinchmann, and J. Olweus
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
Blood, March 1, 2006; 107(5): 2022 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J A Hardin
Dendritic cells: potential triggers of autoimmunity and targets for therapy
Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv86 - iv90.
[Full Text] [PDF]


Home page
J. Immunol.Home page
H. Hashizume, T. Horibe, H. Yagi, N. Seo, and M. Takigawa
Compartmental Imbalance and Aberrant Immune Function of Blood CD123+ (Plasmacytoid) and CD11c+ (Myeloid) Dendritic Cells in Atopic Dermatitis
J. Immunol., February 15, 2005; 174(4): 2396 - 2403.
[Abstract] [Full Text] [PDF]



Advertisement